Chief Medical Officer Royal holds a webcast entitled, "Empowering the Lymphatics: Unleashing the Potential of Biologics that Target the Immune System" on November 17 at 11:30 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on SRNE:
- Sorrento Therapeutics options imply 5.7% move in share price post-earnings
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Sorrento Therapeutics initiated with an Overweight at Cantor Fitzgerald
- Scilex, Vickers Vantage Corp I announce effectiveness of registration statement
- Scilex Holding Company (“Scilex”), a Sorrento Company (nearly 100% or over 99.9% majority-owned subsidiary of Sorrento Therapeutics, Inc.) (Nasdaq: SRNE, “Sorrento”), and Vickers Vantage Corp. I Announce Effectiveness of Registration Statement on Form S-4, Date of Vickers Vantage Extraordinary General Meeting to Approve Proposed Business Combination